{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:43:46Z","timestamp":1787870626816,"version":"build-2784847793"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.tranon.2026.102922","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:29:47Z","timestamp":1784204987000},"page":"102922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The role of splicing factor SRSF3 in cancer progression: Mechanisms, biomarkers, and therapeutic implications"],"prefix":"10.1016","volume":"71","author":[{"given":"Shidong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangjie","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.tranon.2026.102922_bib0001","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.7150\/jca.42645","article-title":"Aberrant expression and regulatory network of splicing factor-SRSF3 in tumors","volume":"11","author":"Che","year":"2020","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.tranon.2026.102922_bib0002","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbrc.2016.01.019","article-title":"SRSF3 represses the expression of PDCD4 protein by coordinated regulation of alternative splicing, export and translation","volume":"470","author":"Park","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tranon.2026.102922_bib0003","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ncomms2342","article-title":"Splicing factor SRSF3 is crucial for hepatocyte differentiation and metabolic function","volume":"4","author":"Sen","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.102922_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.577636","article-title":"Emerging roles of SRSF3 as a therapeutic target for cancer","volume":"10","author":"Zhou","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102922_bib0005","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1038\/s41467-022-31364-7","article-title":"hnRNPH1 recruits PTBP2 and SRSF3 to modulate alternative splicing in germ cells","volume":"13","author":"Feng","year":"2022","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.tranon.2026.102922_bib0006","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.7150\/ijbs.83368","article-title":"Oncogenic SRSF3 in health and diseases","volume":"19","author":"Jia","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.tranon.2026.102922_bib0007","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/cdd.2013.171","article-title":"Splicing factor SRSF3 represses the translation of programmed cell death 4 mRNA by associating with the 5\u2032-UTR region","volume":"21","author":"Kim","year":"2014","journal-title":"Cell Death. Differ."},{"issue":"11","key":"10.1016\/j.tranon.2026.102922_bib0008","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41419-022-05371-x","article-title":"Splicing factor SRSF3 represses translation of p21(cip1\/waf1) mRNA","volume":"13","author":"Kim","year":"2022","journal-title":"Cell Death. Dis."},{"issue":"7","key":"10.1016\/j.tranon.2026.102922_bib0009","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70395","article-title":"SRSF3 Inhibits high glucose and palmitic acid-induced cardiomyocyte apoptosis through the PI3K\/AKT and NF-\u03bab pathways","volume":"39","author":"Gao","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"11","key":"10.1016\/j.tranon.2026.102922_bib0010","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1093\/brain\/awaa273","article-title":"Splicing machinery dysregulation drives glioblastoma development\/aggressiveness: oncogenic role of SRSF3","volume":"143","author":"Fuentes-Fayos","year":"2020","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.tranon.2026.102922_bib0011","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2334\/josnusd.18-0485","article-title":"Underexpression of SRSF3 and its target gene RBMX predicts good prognosis in patients with head and neck cancer","volume":"62","author":"Guo","year":"2020","journal-title":"J. Oral Sci."},{"issue":"4","key":"10.1016\/j.tranon.2026.102922_bib0012","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/nar\/gkv1500","article-title":"A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells","volume":"44","author":"Ajiro","year":"2016","journal-title":"Nucleic. Acids. Res."},{"issue":"10","key":"10.1016\/j.tranon.2026.102922_bib0013","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.3390\/cells9102325","article-title":"SRSF3 Is a critical requirement for inclusion of exon 3 of BIS pre-mRNA","volume":"9","author":"Baek","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.tranon.2026.102922_bib0014","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbrc.2021.09.019","article-title":"Identification of SRSF3 target mRNAs using inducible TRIBE","volume":"578","author":"Jin","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.tranon.2026.102922_bib0015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3390\/cimb45010039","article-title":"Cooperative binding of SRSF3 to structured 3\u2032ss-\u03b1 exon RNA during \u03b1 exon inclusion in the ZO-1 mRNA","volume":"45","author":"Ruiz-Luis","year":"2023","journal-title":"Curr. Issues. Mol. Biol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102922_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2023.100089","article-title":"Revisiting and corrections to the annotated SRSF3 (SRp20) gene structure and RefSeq sequences from the human and mouse genomes","volume":"2","author":"Yu","year":"2023","journal-title":"Cell Insight."},{"issue":"10","key":"10.1016\/j.tranon.2026.102922_bib0017","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/15476286.2015.1076610","article-title":"SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells","volume":"12","author":"Gautrey","year":"2015","journal-title":"RNa Biol."},{"key":"10.1016\/j.tranon.2026.102922_bib0018","doi-asserted-by":"crossref","DOI":"10.1038\/srep35976","article-title":"HnRNP L is important for the expression of oncogene SRSF3 and oncogenic potential of oral squamous cell carcinoma cells","volume":"6","author":"Jia","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.tranon.2026.102922_bib0019","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.3390\/ijms19103012","article-title":"SRSF3, a splicer of the PKM gene, regulates cell growth and maintenance of cancer-specific energy metabolism in colon cancer cells","volume":"19","author":"Kuranaga","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.tranon.2026.102922_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314832","article-title":"SRSF3 and HNRNPH1 regulate radiation-induced alternative splicing of protein arginine methyltransferase 5 in hepatocellular carcinoma","volume":"23","author":"Wen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.102922_bib0021","first-page":"1","article-title":"Inclusion of hnRNP L alternative exon 7 is associated with good prognosis and inhibited by oncogene SRSF3 in head and neck squamous cell carcinoma","volume":"2019","author":"Xu","year":"2019","journal-title":"Biomed. Res. Int."},{"issue":"13","key":"10.1016\/j.tranon.2026.102922_bib0022","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1039\/C7RA11267J","article-title":"Inhibition of the expression of oncogene SRSF3 by blocking an exonic splicing suppressor with antisense oligonucleotides","volume":"8","author":"Guo","year":"2018","journal-title":"RSC. Adv."},{"issue":"4","key":"10.1016\/j.tranon.2026.102922_bib0023","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.3390\/ijms24043872","article-title":"SRSF3-Mediated Ki67 exon 7-inclusion promotes head and neck squamous cell carcinoma progression via repressing AKR1C2","volume":"24","author":"Liu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.tranon.2026.102922_bib0024","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.4922","article-title":"The potential role of necroptosis in clinical diseases (Review)","volume":"47","author":"Dai","year":"2021","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.tranon.2026.102922_bib0025","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.18632\/oncotarget.14184","article-title":"MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2026.102922_bib0026","article-title":"SRSF3 is oncogenic in breast but tumor-suppressive in liver by differential regulation of gene expression","author":"Yu","year":"2025","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.tranon.2026.102922_bib0027","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bbagrm.2013.11.006","article-title":"Exon 9 skipping of apoptotic caspase-2 pre-mRNA is promoted by SRSF3 through interaction with exon 8","volume":"1839","author":"Jang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"22","key":"10.1016\/j.tranon.2026.102922_bib0028","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1038\/onc.2012.288","article-title":"Downregulation of splicing factor SRSF3 induces p53\u03b2, an alternatively spliced isoform of p53 that promotes cellular senescence","volume":"32","author":"Tang","year":"2013","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.tranon.2026.102922_bib0029","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1182\/blood.2021013826","article-title":"The RNA-binding protein SRSF3 has an essential role in megakaryocyte maturation and platelet production","volume":"139","author":"Heazlewood","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.tranon.2026.102922_bib0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12915-021-01103-3","article-title":"FGF-2 promotes angiogenesis through a SRSF1\/SRSF3\/SRPK1-dependent axis that controls VEGFR1 splicing in endothelial cells","volume":"19","author":"Jia","year":"2021","journal-title":"BMC. Biol."},{"key":"10.1016\/j.tranon.2026.102922_bib0031","article-title":"LINC01210 promotes malignant phenotypes of colorectal cancer through epigenetically upregulating SRSF3","volume":"234","author":"Luo","year":"2022","journal-title":"Pathol. Res. Pr."},{"issue":"8","key":"10.1016\/j.tranon.2026.102922_bib0032","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1007\/s10620-023-07977-3","article-title":"Homeobox B9 promotes colon cancer progression by targeting SRSF3","volume":"68","author":"Yuan","year":"2023","journal-title":"Dig. Dis. Sci."},{"issue":"4","key":"10.1016\/j.tranon.2026.102922_bib0033","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/jgh.16152","article-title":"Genetic compensation response could exist in colorectal cancer: UPF3A upregulates the oncogenic homologue gene SRSF3 expression corresponding to SRSF6 to promote colorectal cancer metastasis","volume":"38","author":"Xu","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102922_bib0034","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yexcr.2017.06.009","article-title":"SRSF3-regulated miR-132\/212 controls cell migration and invasion by targeting YAP1","volume":"358","author":"Kim","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.tranon.2026.102922_bib0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.phrs.2019.03.008","article-title":"Cortisol-induced SRSF3 expression promotes GR splicing, RACK1 expression and breast cancer cells migration","volume":"143","author":"Buoso","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tranon.2026.102922_bib0036","article-title":"SRSF3 Promotes angiogenesis in colorectal cancer by splicing SRF","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2026.102922_bib0037","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12935-020-01201-2","article-title":"SRSF3 functions as an oncogene in colorectal cancer by regulating the expression of ArhGAP30","volume":"20","author":"Wang","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.tranon.2026.102922_bib0038","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbamcr.2017.11.005","article-title":"RBM4-SRSF3-MAP4K4 splicing cascade modulates the metastatic signature of colorectal cancer cell","volume":"1865","author":"Lin","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.102922_bib0039","article-title":"SRSF3 undergoes phase separation in lung cancer and is associated with immunity and ferroptosis","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.tranon.2026.102922_bib0040","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/bgaf082","article-title":"SRSF3 knockdown-induced cellular senescence as a possible therapeutic strategy for non-small cell lung cancer","volume":"46","author":"Nakamichi","year":"2025","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.tranon.2026.102922_bib0041","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12967-023-04812-1","article-title":"Circular RNA hsa_circ_0050386 suppresses non-small cell lung cancer progression via regulating the SRSF3\/FN1 axis","volume":"22","author":"Chen","year":"2024","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.tranon.2026.102922_bib0042","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/mc.23477","article-title":"Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5","volume":"62","author":"Che","year":"2023","journal-title":"Mol. Carcinog."},{"issue":"8","key":"10.1016\/j.tranon.2026.102922_bib0043","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41419-023-06034-1","article-title":"SRSF3\/AMOTL1 splicing axis promotes the tumorigenesis of nasopharyngeal carcinoma through regulating the nucleus translocation of YAP1","volume":"14","author":"Xu","year":"2023","journal-title":"Cell Death. Dis."},{"issue":"2","key":"10.1016\/j.tranon.2026.102922_bib0044","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00262-020-02683-9","article-title":"B7-H3 is spliced by SRSF3 in colorectal cancer","volume":"70","author":"Zhang","year":"2021","journal-title":"Cancer Immunol. Immunother.: CII"},{"issue":"6","key":"10.1016\/j.tranon.2026.102922_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110813","article-title":"SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine","volume":"39","author":"Wang","year":"2022","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.tranon.2026.102922_bib0046","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23646","article-title":"SCARB1-encoded circ _0029343 induces p73 splicing to promote growth and metastasis of hepatocellular carcinoma via miR-486-5p\/SRSF3 axis","volume":"38","author":"Zhu","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"8","key":"10.1016\/j.tranon.2026.102922_bib0047","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41419-021-04013-y","article-title":"PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.tranon.2026.102922_bib0048","article-title":"Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer","volume":"51","author":"Jim\u00e9nez-Vacas","year":"2020","journal-title":"EBio Med."},{"issue":"4","key":"10.1016\/j.tranon.2026.102922_bib0049","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.bbrc.2019.01.048","article-title":"Oncogene SRSF3 suppresses autophagy via inhibiting BECN1 expression","volume":"509","author":"Zhou","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tranon.2026.102922_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111280","article-title":"An anti-PD-1 antisense oligonucleotide promotes the expression of soluble PD-1 by blocking the interaction between SRSF3 and an exonic splicing enhancer of PD-1 exon 3","volume":"126","author":"Wang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102922_bib0051","doi-asserted-by":"crossref","first-page":"102","DOI":"10.14712\/fb2021067030102","article-title":"Inhibition of SRSF3 alleviates proliferation and migration of gastric cancer cells by regulating the PI3K\/AKT\/mTOR signalling pathway","volume":"67","author":"Xie","year":"2021","journal-title":"Folia Biol. (Krakow)"},{"issue":"24","key":"10.1016\/j.tranon.2026.102922_bib0052","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.2174\/0929867326666190517115515","article-title":"B7-H3 Immune checkpoint protein in Human cancer","volume":"27","author":"Flem-Karlsen","year":"2020","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.tranon.2026.102922_bib0053","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00262-021-03097-x","article-title":"Targeting the immune checkpoint B7-H3 for next-generation cancer immunotherapy","volume":"71","author":"Liu","year":"2022","journal-title":"Cancer Immunol. Immunther."},{"issue":"1","key":"10.1016\/j.tranon.2026.102922_bib0054","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s12672-024-01674-x","article-title":"Immune checkpoint B7-H3 is a potential therapeutic target in prostate cancer","volume":"15","author":"Shen","year":"2024","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102922_bib0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13045-022-01364-7","article-title":"Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy","volume":"15","author":"Zhao","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tranon.2026.102922_bib0056","article-title":"B7-H3\/CD276: an emerging cancer immunotherapy","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.tranon.2026.102922_bib0057","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1261\/rna.068619.118","article-title":"Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation","volume":"25","author":"Jia","year":"2019","journal-title":"RNA"},{"issue":"8","key":"10.1016\/j.tranon.2026.102922_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2024.119841","article-title":"SRSF3 suppresses RCC tumorigenesis and progression via regulating SP4 alternative splicing","volume":"1871","author":"Zhang","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"8","key":"10.1016\/j.tranon.2026.102922_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113113","article-title":"NXF1 suppresses progression of endometrial cancer by interacting with the SRSF3 to regulate SP4 splicing","volume":"28","author":"Meng","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.tranon.2026.102922_bib0060","first-page":"6","article-title":"YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs","author":"Roundtree","year":"2017","journal-title":"Elife"},{"issue":"9","key":"10.1016\/j.tranon.2026.102922_bib0061","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3390\/cells11091461","article-title":"Multiple phosphorylations of SR protein SRSF3 and its binding to m(6)A reader YTHDC1 in Human cells","volume":"11","author":"Tatsuno","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.tranon.2026.102922_bib0062","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12943-015-0422-1","article-title":"Serine\/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair","volume":"14","author":"He","year":"2015","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2026.102922_bib0063","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.21873\/anticanres.14160","article-title":"SRSF3 Depletion leads to an increase in SF3B4 expression in SNU-368 HCC cells","volume":"40","author":"Lee","year":"2020","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.tranon.2026.102922_bib0064","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7150\/ijms.14871","article-title":"Expression of SRSF3 is correlated with carcinogenesis and progression of oral squamous cell carcinoma","volume":"13","author":"Peiqi","year":"2016","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.tranon.2026.102922_bib0065","article-title":"SRSF3 Expression serves as a potential biomarker for prognostic and immune response in Pan-cancer","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.tranon.2026.102922_bib0066","doi-asserted-by":"crossref","first-page":"8751","DOI":"10.3390\/ijms24108751","article-title":"miR-486 responds to apoptosis and autophagy by repressing SRSF3 expression in ovarian granulosa cells of dairy goats","volume":"24","author":"Liu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.102922_bib0067","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plasmid.2015.07.004","article-title":"Construction and evaluation of an adenoviral vector for the liver-specific expression of the serine\/arginine-rich splicing factor, SRSF3","volume":"82","author":"Suchanek","year":"2015","journal-title":"Plasmid"},{"issue":"5","key":"10.1016\/j.tranon.2026.102922_bib0068","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0296565","article-title":"Intronic miR-6741-3p targets the oncogene SRSF3: implications for oral squamous cell carcinoma pathogenesis","volume":"19","author":"More","year":"2024","journal-title":"PLoS. One"},{"issue":"2","key":"10.1016\/j.tranon.2026.102922_bib0069","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41419-022-04542-0","article-title":"LINC01123 promotes immune escape by sponging miR-214-3p to regulate B7-H3 in head and neck squamous-cell carcinoma","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death. Dis."},{"issue":"1","key":"10.1016\/j.tranon.2026.102922_bib0070","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41467-023-36881-7","article-title":"Henske EP: mTORC1 upregulates B7-H3\/CD276 to inhibit antitumor T cells and drive tumor immune evasion","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"issue":"Suppl 4","key":"10.1016\/j.tranon.2026.102922_bib0071","doi-asserted-by":"crossref","first-page":"S546","DOI":"10.1245\/s10434-014-3564-2","article-title":"Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patients","volume":"21","author":"Maeda","year":"2014","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102922_bib0072","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/03936155251367774","article-title":"SH3GL1 mediates B7-H3 recycling and enhances the immune escape in non-small cell lung cancer","volume":"40","author":"Nu Er Lan","year":"2025","journal-title":"Int. J. Biol. Markers"},{"issue":"1","key":"10.1016\/j.tranon.2026.102922_bib0073","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41420-021-00527-8","article-title":"MicroRNA-326 attenuates immune escape and prevents metastasis in lung adenocarcinoma by targeting PD-L1 and B7-H3","volume":"7","author":"Shao","year":"2021","journal-title":"Cell Death. Discov."},{"issue":"1","key":"10.1016\/j.tranon.2026.102922_bib0074","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3892\/ol.2021.13139","article-title":"Biological function and molecular mechanism of SRSF3 in cancer and beyond","volume":"23","author":"Xiong","year":"2022","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.tranon.2026.102922_bib0075","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41420-022-01039-9","article-title":"A novel SRSF3 inhibitor, SFI003, exerts anticancer activity against colorectal cancer by modulating the SRSF3\/DHCR24\/ROS axis","volume":"8","author":"Zhang","year":"2022","journal-title":"Cell Death. Discov."},{"key":"10.1016\/j.tranon.2026.102922_bib0076","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2147\/DDDT.S507402","article-title":"Lipid nanovesicles in cancer treatment: improving targeting and stability of antisense oligonucleotides","volume":"19","author":"Ding","year":"2025","journal-title":"Drug. Devel. Ther."},{"issue":"1","key":"10.1016\/j.tranon.2026.102922_bib0077","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1517\/14712598.5.1.67","article-title":"Antisense oligonucleotides in the treatment of bladder cancer","volume":"5","author":"Glackin","year":"2005","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"9","key":"10.1016\/j.tranon.2026.102922_bib0078","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/s41416-024-02859-5","article-title":"Dual-modified antisense oligonucleotides targeting oncogenic protocadherin to treat gastric cancer","volume":"131","author":"Kanda","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"22","key":"10.1016\/j.tranon.2026.102922_bib0079","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3390\/cells13221869","article-title":"Clinical applications of antisense oligonucleotides in cancer: a focus on glioblastoma","volume":"13","author":"Khuu","year":"2024","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.tranon.2026.102922_bib0080","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/0008-5472.CAN-20-0948","article-title":"ASO-based PKM splice-switching therapy inhibits hepatocellular carcinoma growth","volume":"82","author":"Ma","year":"2022","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.tranon.2026.102922_bib0081","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00280-019-03945-9","article-title":"Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment","volume":"84","author":"Sun","year":"2019","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1016\/j.tranon.2026.102922_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101292","article-title":"Targeting CLK1\/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy and immunotherapy","volume":"83","author":"Zhang","year":"2025","journal-title":"Drug Resist. Updates: Rev. Comment. Antimicrob. Anticancer Chemother."},{"issue":"7","key":"10.1016\/j.tranon.2026.102922_bib0083","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202256021","article-title":"SRSF3 shapes the structure of miR-17-92 cluster RNA and promotes selective processing of miR-17 and miR-20a","volume":"24","author":"Ratnadiwakara","year":"2023","journal-title":"EMBo Rep."},{"issue":"1","key":"10.1016\/j.tranon.2026.102922_bib0084","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-021-01434-3","article-title":"Proteolysis-targeting chimeras (PROTACs) in cancer therapy","volume":"21","author":"Li","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.102922_bib0085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cell.2019.11.031","article-title":"Proteolysis-targeting chimeras as therapeutics and tools for biological discovery","volume":"181","author":"Burslem","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.tranon.2026.102922_bib0086","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13045-021-01072-8","article-title":"CLK1\/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer","volume":"14","author":"Chen","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.tranon.2026.102922_bib0087","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1158\/1541-7786.MCR-12-0213","article-title":"Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1","volume":"10","author":"Mu\u00f1oz","year":"2012","journal-title":"Mol. Cancer Res.: MCR"},{"issue":"41","key":"10.1016\/j.tranon.2026.102922_bib0088","doi-asserted-by":"crossref","first-page":"13965","DOI":"10.1074\/jbc.RA120.013820","article-title":"Alternative splicing reverses the cell-intrinsic and cell-extrinsic pro-oncogenic potentials of YAP1","volume":"295","author":"Ben","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tranon.2026.102922_bib0089","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2023.07.054","article-title":"Lipid nanoparticles for siRNA delivery in cancer treatment","volume":"361","author":"El Moukhtari","year":"2023","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"issue":"5","key":"10.1016\/j.tranon.2026.102922_bib0090","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1021\/acsbiomaterials.3c01749","article-title":"Ordered mesoporous silica delivering siRNA as cancer nanotherapeutics: a comprehensive review","volume":"10","author":"Gupta","year":"2024","journal-title":"ACS. Biomater. Sci. Eng."},{"issue":"7","key":"10.1016\/j.tranon.2026.102922_bib0091","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther.: J. Am. Soc. Gene Ther."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326002585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326002585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:30:14Z","timestamp":1787225414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326002585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":91,"alternative-id":["S1936523326002585"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102922","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of splicing factor SRSF3 in cancer progression: Mechanisms, biomarkers, and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102922"}}